Literature DB >> 27555348

Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].

Alessandro Armuzzi1, Paolo Gionchetti2, Marco Daperno3, Silvio Danese4, Ambrogio Orlando5, Maria Lia Scribano6, Maurizio Vecchi7, Fernando Rizzello8.   

Abstract

Entities:  

Year:  2016        PMID： 27555348     DOI： 10.1016/j.dld.2016.06.015

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  1 in total

1.  Vedolizumab-Induced De Novo Extraintestinal Manifestations.

Authors:  Liege I Diaz; Tara Keihanian; Ingrid Schwartz; Su Bin Kim; Fernando Calmet; Maria Alejandra Quintero; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.